László Gopcsa, Marienn Réti, Hajnalka Andrikovics, Ilona Bobek, Gabriella Bekő, Judit Bogyó, Andrea Ceglédi, Katalin Dobos, Laura Giba-Kiss, István Jankovics, Orsolya Kis, Botond Lakatos, Dóra Mathiász, Nóra Meggyesi, Gottfried Miskolczi, Noémi Németh, Melinda Paksi, Alexandra Riczu, János Sinkó, Bálint Szabó, Anikó Szilvási, János Szlávik, Szabolcs Tasnády, Péter Reményi, István Vályi-Nagy
The COVID-19 pandemic has exacerbated mortality rates among immunocompromised patients, accentuating the need for novel, targeted therapies. Transplant recipients, with their inherent immune vulnerabilities, represent a subgroup at significantly heightened risk. Current conventional therapies often demonstrate limited effectiveness in these patients, calling for innovative treatment approaches. In immunocompromised transplant recipients, several viral infections have been successfully treated by adoptive transfer of virus-specific T-cells (VST)...
July 6, 2023: GeroScience